Jianrong Wu

Also affiliated with University Health Network, The University of Texas MD Anderson Cancer Center, University of New Mexico, Sichuan University, Fujian Provincial Hospital

MedicineMathematicsDecision SciencesBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “MYCN amplification and ATRX mutations are incompatible in neuroblastoma”.

MYCN amplification and ATRX mutations are incompatible in neuroblastoma

Nature Communications(2020)10.1038/s41467-020-14682-6

N/A

0DataRank · unranked

129 citations

Sara M. Federico, Xiang Chen, Yiping Fan, Beisi Xu, Elizabeth Stewart +32 more

Topotecan clearance based on a single sample and a population pharmacokinetic model: Application to a pediatric high‐risk neuroblastoma clinical trial

Pediatric Blood & Cancer(2023)10.1002/pbc.30658

N/A

0DataRank · unranked

0 citations

Huiyun Wu, Jianrong Wu, Arlene Naranjo, Vinay M. Daryani, Amar Gajjar +3 more

BayCAR: a Bayesian-based covariate-adaptive randomization method for multi-arm trials

Communications in Statistics - Simulation and Computation(2024)10.1080/03610918.2024.2443202

N/A

0DataRank · unranked

0 citations

Jianrong Wu, Shengping Yang